Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03066726 · ClinicalTrials.gov registry record
Does the Cerebroplacental Ratio (CPR) Predict Adverse Outcomes in Low Risk Pregnancies?
A clinical trial, sponsored by Rutgers, The State University of New Jersey.
- Terminated
- Registry status
- 580
- Enrollment target
NCT03066726 is a clinical trial that was terminated before completion, run by Rutgers, The State University of New Jersey. The registered enrollment target is 580 participants.
The verdict
NCT03066726 was terminated before completion, sponsored by Rutgers, The State University of New Jersey.
- TERMINATED
- Registry status
- 580 participants
- Enrollment target
Study Summary
Ultrasound Doppler studies are used during pregnancy to help manage pregnancies complicated by fetal growth restriction. The cerebroplacental ratio may predict adverse outcomes in low risk pregnancies. In a prospective study, the investigators will examine whether fetuses with an abnormal CPR at or near term are at increased risk for being delivered by cesarean,
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 580 participants |
| Start Date | 2017-05-15 |
| Est. Completion | 2020-05-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03066726
The ClinicalTrials.gov registry entry for NCT03066726 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 580 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03066726 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03066726 about?
NCT03066726 is a clinical study titled "Does the Cerebroplacental Ratio (CPR) Predict Adverse Outcomes in Low Risk Pregnancies?". Ultrasound Doppler studies are used during pregnancy to help manage pregnancies complicated by fetal growth restriction. The cerebroplacental ratio may predict adverse outcomes in low risk pregnancies. In a prospective study, the investigators will examine whether fetuses with an abnormal CPR at or ...
What is the current status of trial NCT03066726?
This trial is currently terminated. The enrollment target is 580 participants. The study started on 2017-05-15. Estimated completion is 2020-05-07.
Who is sponsoring clinical trial NCT03066726?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.